Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer
NCT04720508 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2021-01-22
Summary
In this study we aim to:
1. Assess serum miRNA-373, miRNA-425-5p expression in patients with breast cancer.
2. Explore their correlations with breast cancer clinicopathological documented data including staging, grading and tumor receptors.
Conditions
Interventions
- DIAGNOSTIC_TEST
-
blood sample collection.
venipuncture procedure
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-01
- Primary Completion
- 2023-10-25
- Completion
- 2023-12-25
More Related Trials
-
MIRNA Profiling of Breast Cancer in Patients Undergoing Neoadjuvant or Adjuvant Treatment for Locally Advanced & Inflammatory Breast Cancer
NCT01231386 ·Status: COMPLETED
-
The Effect of Metformin on Breast Cancer Patients
NCT04559308 ·Status: UNKNOWN ·Phase: PHASE2
-
MicroRNAs and Prognosis in Breast Cancer
NCT06555354 ·Status: COMPLETED
-
Evaluation of Breast Cancer Screening Program at Assiut Governorate
NCT06403917 ·Status: NOT_YET_RECRUITING
-
Prognostic Significance of Bioscore in Nonmetastatic Breast Cancer
NCT03638219 ·Status: COMPLETED
-
Comparative Expression of ER,PR and HER2/Neu in Initial and Recurrent Breast Cancer.
NCT07056205 ·Status: ENROLLING_BY_INVITATION
-
Circulating miRNAs.
NCT01722851 ·Status: COMPLETED
-
microRNA of Human Epidermal Growth Factor Receptor 2 （HER2）Positive Patient Treated With Herceptin
NCT02656589 ·Status: UNKNOWN
-
miRNA and Relevant Biomarkers of BC Patients Undergoing Neoadjuvant Treatment
NCT03779022 ·Status: UNKNOWN
-
Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer
NCT00898703 ·Status: COMPLETED
-
Differential Expression and Potential Value of c-MYC in Non-Invasive and Invasive Mammary Carcinoma
NCT06357338 ·Status: ENROLLING_BY_INVITATION
-
Study of Breast Tissue in Women Not Previously Diagnosed With Breast Cancer Who Are Undergoing Fine Needle Aspiration
NCT00896636 ·Status: UNKNOWN
-
Circular RNA and Chemerin in Breast Cancer Patient
NCT05771337 ·Status: NOT_YET_RECRUITING
-
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population
NCT06357689 ·Status: COMPLETED
-
Can MicroRNA's Predict Multicentricity in Breast Cancer?
NCT04516330 ·Status: COMPLETED ·Phase: NA
-
Correlation Between Fluorodeoxyglucose (FDG) and FLT Uptake and Gene-Expression Oncotype Assay in Patients With Breast Cancer
NCT00688337 ·Status: UNKNOWN
-
Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes
NCT04403984 ·Status: UNKNOWN
-
Cell Free DNA and Its Integrity Using ALU Sequences as a Biomarker for Diagnosis of Breast Cancer
NCT03474016 ·Status: UNKNOWN
-
Concordance of the Biology of Primary Breast Carcinoma and the Biology of Recurrence .
NCT07275203 ·Status: NOT_YET_RECRUITING
-
Comparative Genomic and Genetic Analysis of Paired Primary Breast - Metastatic Tumor Specimens Using High-throughput Platforms
NCT01227733 ·Status: UNKNOWN
-
Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer
NCT00897208 ·Status: COMPLETED
-
Cardiac Toxicity of Hypo Fractionated Radiotherapy in Left Breast Cancer
NCT05358093 ·Status: UNKNOWN
-
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416 ·Status: COMPLETED
-
Clinical Study of Glycosylated Extracellular Vesicles for Early Diagnosis of Breast Cancer
NCT05417048 ·Status: UNKNOWN
-
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
NCT02352883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA